-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Monte Rosa Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2020 to 2023.
- Monte Rosa Therapeutics, Inc. Depreciation for the quarter ending June 30, 2024 was $2.06M, a 48.1% increase year-over-year.
- Monte Rosa Therapeutics, Inc. Depreciation for the twelve months ending June 30, 2024 was $7.64M, a 64.4% increase year-over-year.
- Monte Rosa Therapeutics, Inc. annual Depreciation for 2023 was $6.22M, a 66.1% increase from 2022.
- Monte Rosa Therapeutics, Inc. annual Depreciation for 2022 was $3.75M, a 75.7% increase from 2021.
- Monte Rosa Therapeutics, Inc. annual Depreciation for 2021 was $2.13M, a 297% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)